Targeting RNA oxidation by ISG20-mediated degradation is a potential therapeutic strategy for acute kidney injury.
Jia M, Li L, Chen R, Du J, Qiao Z, Zhou D, Liu M, Wang X, Wu J, Xie Y, Sun Y, Zhang Y, Wang Z, Zhang T, Hu H, Sun J, Tang W, Yi F.
Jia M, et al. Among authors: zhang t, zhang y.
Mol Ther. 2023 Oct 4;31(10):3034-3051. doi: 10.1016/j.ymthe.2023.07.008. Epub 2023 Jul 14.
Mol Ther. 2023.
PMID: 37452495
Free PMC article.